PHASE I STUDY OF INTERFERON ENHANCED INTRAPERITONEAL RADIOIMMUNO-CHEMOTHERAPY FOR OVARIAN CANCER.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Monoclonal antibody 177Lu CC49; Monoclonal antibody CC49 Y-90; Paclitaxel; Topotecan
- Indications Ovarian cancer
- Focus Adverse reactions
- 05 Feb 2013 Biomarkers information updated
- 30 Apr 2011 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified Feb 2001).
- 22 Sep 2005 New trial record.